Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti
Keyword(s):
Abstract We compared viral suppression rates between patients who continued tenofovir disoproxil fumarate (TDF)/lamivudine (3TC) vs switched to zidovudine (ZDV)/3TC in combination with a boosted protease inhibitor after failure of first-line efavirenz/TDF/3TC. We found higher rates of viral suppression with continued TDF/3TC compared with switching to ZDV/3TC.
2017 ◽
Vol 73
(1)
◽
pp. 5-11
◽
Keyword(s):
2015 ◽
Vol 91
(Suppl 2)
◽
pp. A33.3-A34
◽
2013 ◽
Vol 32
(6)
◽
pp. 644-647
◽
Keyword(s):
2019 ◽
Vol 80
(3)
◽
pp. 325-329
◽